XYOTAX

Marca svizra · 547359 · Marca cumbinada · Stizzada

Inscripziun en il register

Numer da registraziun
547359
Numer da la dumonda
53262/2006
Status
Stizzada
Tip
Marca cumbinada
Sco registrada
XYOTAX ((fig.))
Deponida
10-04-2006
Registrada
23-06-2006
Publitgada
11-07-2006
Stizzada
14-11-2016
Motiv
Betg prolungada
Colurs pretendidas
Bleu, jaune.
Prioritad
28.03.2006 US
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Produits pharmaceutiques, notamment, médicaments pour le traitement du cancer.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 14-11-2016

    Stritgà, betg prolungà

    Published in Swissreg on 14.11.2016

  2. 18-06-2007

    Transferì

    Owner
    Cell Therapeutics, Inc., 501 Elliott Avenue West, Suite 400, 98119 Seattle, Washington, USA → Novartis AG, 4002 Basel
    Representative
    Jacobacci & Partners S.A., 2, avenue de la Gare des Eaux-Vives, 1207 Genève → NOVARTIS INTERNATIONAL AG, Corporate Intellectual Property, Global Trademark Section, 4002 BASEL

    Published in the SOGC no. 115 of 18.06.2007

  3. 11-07-2006

    Registrà

    Published in the SOGC no. 132 of 11.07.2006

Partidas

Possessura

Novartis AG

4002 Basel

Represententa

Novartis International AG

NOVARTIS INTERNATIONAL AG Corporate Intellectual Property Global Trademark Section

4002 BASEL

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.